Clinical Trial Update: IFM 2005-01: Velcade/Dexamethasone Versus Vincristine/Adriamycin (Doxorubicin)/Dexamethasone (VAD) for the Treatment of Patients With Multiple Myeloma [Phase 3]

View source ↗

Summary

A Phase 3 trial (IFM 2005-01) comparing Velcade plus dexamethasone versus Vincristine/Adriamycin/Dexamethasone in patients with multiple myeloma; the study has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Adriamycin (doxorubicin)
• DEXAMETHASONE (Dexamethasone)
• Velcade (bortezomib)
• Vincristine (vincristine)

Snippet

Sponsor: Nantes University Hospital | Conditions: Multiple Myeloma | Phase 3 | Status: COMPLETED